Jane has over 30 years of international experience in the pharmaceutical and biotechnology industries where she has held executive roles in management of research and development programs as well as business development and alliance management. Jane has worked both in Australia, the US and UK with companies including Peptech, Roche, Cambridge Antibody Technology and Biota Holdings. Throughout her career, she has led many successful fundraising campaigns and licensing initiatives including winning a $230m US Government contract for advance development of a drug to treat influenza. Jane currently chairs the Advisory Board at the ithree Institute at the University of Technology Sydney (UTS) which studies how microbes grow, live, adapt and survive. She is also currently a Board Member of Victorian endowment for Science Knowledge and Innovation (veski), Part time Vice President Research and Development at Reef Pharmaceuticals and advisor to Opal Pharmaceuticals. Jane was previously a Board Member of Diabetes Victoria, TechInSA, Victorian Endowment for Science Knowledge and Innovation and the Diabetes Vaccine Development Centre. Jane is assisting CSIRO with its GMP protein manufacture initiative.